COVID-19

News

Millions of Australians download coronavirus contact tracing...

More than two million people in Australia have downloaded a coronavirus tracing app developed by the country’s government a day after its release.

News

No takeover approach, says COVID-19 vaccine developer BioNTe...

Germany’s BioNTech has said it has not received any takeover approaches after it began a high-profile coronavirus vaccine trial with Pfizer in Germany, following press reports over the week

Views & Analysis

‘More people will die from pancreatic cancer’: How COVID-19 ...

More people with pancreatic cancer will die from the disease if the COVID-19 crisis continues to demand the lion’s share of clinical time and resources.

News

hydroxychloroquine sulphate tablets, in evaluation for treatment of COVID-19.Denmark, Mars 22, 2020

EU regulators warn over safety of Trump's favourite COVID dr...

As the search for therapies for COVID-19 continues, European regulators have urged caution over the cardiac side-effects of chloroquine and its close relative hydroxychloroquine.

News

Disputed COVID-19 trial failure reports send Gilead shares d...

Gilead's COVID-19 drug remdesivir seemingly failed to produce an effect according to results of a Chinese clinical trial posted inadvertently on the World Health Organizatio

Views & Analysis

Coronavirus pharma news roundup – 24/04/2020

Research into drugs that could treat or prevent COVID-19 continued full steam ahead this week as the industry puts all its resources into fighting the coronavirus pandemic.

Millions of Australians download coronavirus contact tracing...

No takeover approach, says COVID-19 vaccine developer BioNTe...

‘More people will die from pancreatic cancer’: How COVID-19 ...

EU regulators warn over safety of Trump's favourite COVID dr...

Disputed COVID-19 trial failure reports send Gilead shares d...

Coronavirus pharma news roundup – 24/04/2020

The long-delayed promise of the microbiome, with Sam Possemi...

How to meet your physicians where they are online

COVID-19

Editor's Picks